All News

Six of the world’s most prestigious public drug discovery organisations are joining forces in a bid to improve the conversion rate of basic research into much-needed new therapies

Universities have a pivotal role to play in responding to the Grand Challenges, fostering innovation and creating growth and social wellbeing. How should these institutions respond to this task? asks Lauritz B. Holm-Nielsen, President of Euroscience and Rector of Aarhus University, Denmark

Now is not the time to cut funds for large-scale experimentation. The current economic dilemma of the EU is a golden opportunity to enable innovation breakthroughs at a system level, says Ioan Ciumasu

It’s up to MEPs to ally with the Commission and stop the European Council cutting the proposed €80B research programme, Máire Geoghegan-Quinn, R&D Commissioner, tells the European Parliament as negotiations reach a head

IEA lists 2013 priorities to re-energise deployment of carbon capture and storage.

Following a positive ruling on patents and a decision to maintain funding for embryonic stem cell research in Horizon 2020, things are looking up for regenerative medicine. Now further support is needed to deliver on the therapeutic potential, experts say in a Science|Business Webinar

Sweden has a reputation for great research – but policy leaders there are sounding an alarm about a decline in quality. A new study has implications for policy makers across Europe.

Blade Dynamics uses innovative design to develop the word's longest wind turbine baldes through the assembly of smaller, more accurate and easily manufactured component pieces

Would it be a good idea to have a small claims court for faster, less expensive handling of patent disputes? The US Patent and Trademark Office asks for public comments

Academics, SMEs and large companies are doing much more research in partnership. Science|Business looks back at some of the highlights of the move to open innovation in 2012, and the policy initiatives that are supporting this

2013 promises more delay and infighting over the role of Brussels in European research and innovation. Our pledge: To keep up the pressure for a speedy resolution to disputes over future R&D funding

This week TiGenix reported positive safety data for its stem cell therapy for rheumatoid arthritis. The news highlights the potential of regenerative medicine as Science|Business publishes a special report examining how Europe can build on its leading position in this fast-paced field of research

A bill proposing “technical amendments” to the American Invents Act is silent on the approaching problem of “secret prior art”

Once in force the Act will streamline international registration of industrial designs

The proposed €80B Horizon 2020 programme should give greater weight to mission-driven, problem-solving research, and to post-research development concludes a new study published by EARTO, the European Association of Research and Technology Organisations